Literature DB >> 16164776

Unpacking the depersonalization syndrome: an exploratory factor analysis on the Cambridge Depersonalization Scale.

Mauricio Sierra1, Dawn Baker, Nicholas Medford, Anthony S David.   

Abstract

BACKGROUND: Depersonalization has long been considered a syndrome but there is poor agreement on its constituent symptoms.
METHOD: In order to establish whether different symptoms of depersonalization represent the expression of a single or several underlying dimensions, an exploratory factor analysis on the Cambridge Depersonalization Scale (CDS) was carried out on 138 consecutive patients diagnosed with depersonalization disorder.
RESULTS: Four well determined factors accounting for 73.3% of the variance were extracted. These were labelled 'Anomalous Body Experience'; 'Emotional Numbing'; 'Anomalous Subjective Recall' and 'Alienation from Surroundings'.
CONCLUSIONS: Symptoms of depersonalization belong to distinct but related psychopathological domains.

Entities:  

Mesh:

Year:  2005        PMID: 16164776     DOI: 10.1017/S0033291705005325

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  22 in total

Review 1.  Conjoint activity of anterior insular and anterior cingulate cortex: awareness and response.

Authors:  Nick Medford; Hugo D Critchley
Journal:  Brain Struct Funct       Date:  2010-05-29       Impact factor: 3.270

2.  Disturbed Experience of Self: Psychometric Analysis of the Self-Experience Lifetime Frequency Scale (SELF).

Authors:  Henriëtte Dorothée Heering; Saskia Goedhart; Richard Bruggeman; Wiepke Cahn; Lieuwe de Haan; René S Kahn; Carin J Meijer; Inez Myin-Germeys; Jim van Os; Durk Wiersma
Journal:  Psychopathology       Date:  2016-03-19       Impact factor: 1.944

3.  Prevalence and childhood antecedents of depersonalization syndrome in a UK birth cohort.

Authors:  William E Lee; Charlie H T Kwok; Elaine C M Hunter; Marcus Richards; Anthony S David
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-12-23       Impact factor: 4.328

4.  Ketamine administration in healthy volunteers reproduces aberrant agency experiences associated with schizophrenia.

Authors:  James W Moore; Danielle C Turner; Philip R Corlett; Fernando S Arana; Hannah L Morgan; Antony R Absalom; Ram Adapa; Sanne de Wit; Jessica C Everitt; Jenny M Gardner; Jennifer S Pigott; Patrick Haggard; Paul C Fletcher
Journal:  Cogn Neuropsychiatry       Date:  2011-02-06       Impact factor: 1.871

5.  An interoceptive predictive coding model of conscious presence.

Authors:  Anil K Seth; Keisuke Suzuki; Hugo D Critchley
Journal:  Front Psychol       Date:  2012-01-10

6.  Abnormal cardiovascular sympathetic and parasympathetic responses to physical and emotional stimuli in depersonalization disorder.

Authors:  Andrew P Owens; Anthony S David; David A Low; Christopher J Mathias; Mauricio Sierra-Siegert
Journal:  Front Neurosci       Date:  2015-03-26       Impact factor: 4.677

7.  Trauma-related altered states of consciousness: exploring the 4-D model.

Authors:  Paul A Frewen; Ruth A Lanius
Journal:  J Trauma Dissociation       Date:  2014

8.  The sense of the body in individuals with spinal cord injury.

Authors:  Bigna Lenggenhager; Mariella Pazzaglia; Giorgio Scivoletto; Marco Molinari; Salvatore Maria Aglioti
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

9.  Validity and reliability of the Structured Clinical Interview for Depersonalization-Derealization Spectrum (SCI-DER).

Authors:  Marco Mula; Stefano Pini; Simona Calugi; Matteo Preve; Matteo Masini; Ilaria Giovannini; Ciro Conversano; Paola Rucci; Giovanni B Cassano
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

10.  Fractionating the unitary notion of dissociation: disembodied but not embodied dissociative experiences are associated with exocentric perspective-taking.

Authors:  Jason J Braithwaite; Kelly James; Hayley Dewe; Nick Medford; Chie Takahashi; Klaus Kessler
Journal:  Front Hum Neurosci       Date:  2013-10-30       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.